In a remarkable achievement, Cure Alzheimer’s Fund (CureAlz) has earned a perfect score and Four-Star rating from Charity Navigator for the 13th consecutive year. This recognition underscores the organization’s unwavering commitment to financial transparency and responsible stewardship of donor contributions in the fight against Alzheimer’s disease.
Charity Navigator, the largest independent evaluator of nonprofits in the United States, assesses organizations based on four key metrics: Impact and Measurement, Accountability and Finance, Culture and Community, and Leadership and Adaptability. CureAlz’s perfect score across all four domains places it in an elite category, with less than one-tenth of one percent of rated charities achieving such a distinction.
Meg Smith, CEO of Cure Alzheimer’s Fund, emphasized the significance of this achievement, stating, ‘Receiving a perfect score from Charity Navigator and Four-Star rating for 13 years in a row is a testament to our commitment to responsible stewardship of the donations entrusted to us.’ Smith further assured donors that their contributions directly fund leading scientists in exploring innovative ideas to combat Alzheimer’s disease.
The Four-Star rating designates Cure Alzheimer’s Fund as an official ‘Give with Confidence’ charity, indicating its high impact in Alzheimer’s research, fiscal responsibility, transparency, and adherence to best practices in leadership and organizational culture. This designation is particularly noteworthy given Charity Navigator’s extensive evaluation of over 230,000 organizations since 2001.
Michael Thatcher, president and CEO of Charity Navigator, commended CureAlz, stating, ‘We are delighted to provide Cure Alzheimer’s Fund with third-party accreditation that validates their operational excellence.’ Thatcher expressed enthusiasm for the future accomplishments of CureAlz in the field of Alzheimer’s research.
Since its founding in 2004, Cure Alzheimer’s Fund has made significant contributions to the field of Alzheimer’s research. The organization has provided 917 grants to more than 300 leading researchers worldwide, totaling over $219 million in research funding. These initiatives have led to key breakthroughs in understanding the causes and pathology of Alzheimer’s disease.
One of the most impressive aspects of CureAlz’s financial model is that 100% of every general donation goes directly into its research program. This is made possible by the organization’s Board of Directors, Trustees, and a core group of donors who cover overhead expenses, ensuring that all general donations are fully allocated to research efforts.
In addition to its stellar Charity Navigator rating, Cure Alzheimer’s Fund has also received a Platinum Seal of Transparency from Candid, formerly known as GuideStar, further attesting to its commitment to openness and accountability.
The consistent recognition from Charity Navigator over 13 years highlights Cure Alzheimer’s Fund’s long-term dedication to excellence in nonprofit management and its unwavering focus on advancing Alzheimer’s research. This track record of financial responsibility and impactful research funding positions CureAlz as a trusted leader in the fight against Alzheimer’s disease.
For those interested in learning more about Cure Alzheimer’s Fund and its research initiatives, detailed information is available on their website at CureAlz.org. The organization’s commitment to transparency and efficiency in funding cutting-edge Alzheimer’s research offers hope to millions affected by this devastating disease and sets a high standard for nonprofit organizations in the medical research field.
This news story relied on a press release distributed by News Direct. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Cure Alzheimer’s Fund Achieves Perfect Score and 13th Consecutive Four-Star Rating from Charity Navigator.